We are live on ! Find out more
PDLI

PDL BioPharma, Inc.
PDLI

Delisted

PDLI was delisted on the 30th of December, 2020.

Back to rankings

5 hedge funds and large institutions have $28K invested in PDL BioPharma, Inc. in 2024 Q3 according to their latest regulatory filings, with 0 funds opening new positions, increasing their positions, reducing their positions, and 2 closing their positions.

New
Increased
Maintained
Reduced
Closed

0% more capital invested

Capital invested by funds: $28K → $28K ($0)

29% less funds holding

Funds holding: 7 → 5 (-2)

100% less first-time investments, than exits

New positions opened: 0 | Existing positions closed: 2

Holders
5
Holders Change
-2
Holders Change %
-28.57%
% of All Funds
0.07%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
–
Increased
–
Reduced
–
Closed
2
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

No buyers this quarter

Top Sellers

No sellers this quarter
Name Holding Trade Value Shares
Change 		Change in
Stake
DT
1
Diversified Trust
Tennessee
$26.5K – – –
RhumbLine Advisers
2
RhumbLine Advisers
Massachusetts
$1.51K – – –

PDLI Hedge Fund Activity: Q3 2024 in Review

5 of the 6,964 institutional investors tracked by Wall St. Rank reported a position in PDL BioPharma, Inc. (PDLI) for Q3 2024, worth a combined $28K — unchanged from a quarter earlier.

Sellers outnumbered buyers: 2 funds closed out of PDLI and 0 opened new positions — a net loss of 2 holders — while 0 trimmed existing stakes and 0 added.

  • 5 institutional investors held PDL BioPharma, Inc. (PDLI) as of Q3 2024, down from 7 in Q2 2024.
  • Funds reported $28K of PDL BioPharma, Inc. stock for Q3 2024, unchanged quarter-over-quarter.
  • 0 funds opened new PDL BioPharma, Inc. positions in Q3 2024 and 2 closed out, a net change of -2 holders.

Based on aggregated 13F filings for Q3 2024.